AstraZeneca to Expand Biotech Portfolio with $1B Acquisition of EsoBiotec

AstraZeneca announces a $1 billion acquisition of EsoBiotec SA, aiming to enhance its biotech portfolio and advance innovative cell therapies globally. The deal, expected to close ...